Maria Grazia Spillantini

Maria Grazia Spillantini

University of Cambridge

H-index: 101

Europe-United Kingdom

About Maria Grazia Spillantini

Maria Grazia Spillantini, With an exceptional h-index of 101 and a recent h-index of 62 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of Neurodegenerative diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and …

The pathogenesis of Parkinson's disease

Tau and neurodegeneration

New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy

Aging, Parkinson’s disease, and models: what are the challenges?

Diagnostic value of salivary biomarkers in Parkinson’s Disease.

Dopamine dorsal raphe dysfunction along with norepinephrine from the locus coeruleus are linked to anxiety and depression in a progressive mouse model of Parkinson's disease.

Salivary α‐synuclein RT‐QuIC correlates with disease severity in de novo Parkinson's disease

Maria Grazia Spillantini Information

University

Position

___

Citations(all)

58170

Citations(since 2020)

18252

Cited By

46387

hIndex(all)

101

hIndex(since 2020)

62

i10Index(all)

217

i10Index(since 2020)

167

Email

University Profile Page

University of Cambridge

Google Scholar

View Google Scholar Profile

Maria Grazia Spillantini Skills & Research Interests

Neurodegenerative diseases

Top articles of Maria Grazia Spillantini

Title

Journal

Author(s)

Publication Date

Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and …

The Journals of Gerontology: Series A,

He-Ling Wang

Richard Siow

Tomas Schmauck-Medina

Jianying Zhang

Per Morten Sandset

...

2024/1/30

The pathogenesis of Parkinson's disease

Huw R Morris

Maria Grazia Spillantini

Carolyn M Sue

Caroline H Williams-Gray

2024/1/20

Tau and neurodegeneration

Michel Goedert

R Anthony Crowther

Sjors HW Scheres

Maria Grazia Spillantini

2024/1

New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy

Acta Neuropathologica

Yang Yang

Holly J Garringer

Yang Shi

Sofia Lövestam

Sew Peak-Chew

...

2023/5

Aging, Parkinson’s disease, and models: what are the challenges?

Aging Biology

I Bellantuono

H Mortiboys

E Rocha

M Chamoli

SJ Chinta

...

2023/7/28

Diagnostic value of salivary biomarkers in Parkinson’s Disease.

Italian Journal of Anatomy & Embryology/Archivio Italiano di Anatomia Ed Embriologia

Claudia Caturano

Francesco Bellomi

Mattew Mason

Mariailenia De Bartolo

Martyna Podgajna

...

2023/1/2

Dopamine dorsal raphe dysfunction along with norepinephrine from the locus coeruleus are linked to anxiety and depression in a progressive mouse model of Parkinson's disease.

Adrián Sanz-Magro

Noelia Granado

M García-Verdugo

C Salas

Samuel Alberquilla

...

2023/6/13

Salivary α‐synuclein RT‐QuIC correlates with disease severity in de novo Parkinson's disease

Movement Disorders

Giorgio Vivacqua

Matthew Mason

Maria Ilenia De Bartolo

Michal Węgrzynowicz

Laura Calò

...

2023/1

Targeting tau degradation: a viable therapeutic approach?

The Lancet Neurology

Matthew Mason

Mehtap Bacioglu

Giorgio Vivacqua

Maria Grazia Spillantini

Aviva M Tolkovsky

2023/6/1

Establishment of Cerebral Organoid‐like Structures from Dental Pulp Stem Cells (DPSCs) to Model Neurodegenerative Diseases.

Alzheimer's & Dementia

Andres‐Ivan Gutierrez‐Malacara

Maria del Carmen Silva‐Lucero

Gustavo Lopez‐Toledo

Laura Gomez‐Virgilio

Maria del Carmen Cardenas‐Aguayo

2023/6

Prioritization of drug targets for neurodegenerative diseases by integrating genetic and proteomic data from brain and blood

Biological psychiatry

Yi-Jun Ge

Ya-Nan Ou

Yue-Ting Deng

Bang-Sheng Wu

Liu Yang

...

2023/5/1

Dysfunctional dorsal raphe dopaminergic neurons and locus coeruleus noradrenergic neurons cause anxiety and depression in a Parkinson’s disease mouse model

Rosario Moratalla

Adrian Sanz-Magro

Noelia Granado

Mario García-Verdugo

Carlos Salas

...

2023/10/13

The role of Rab proteins in Parkinson’s disease synaptopathy

Arianna Bellucci

Francesca Longhena

Maria Grazia Spillantini

2022/8/10

Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype

Molecular Therapy

Gaia Faustini

Francesca Longhena

Anna Masato

Valentina Bassareo

Roberto Frau

...

2022/4/6

In vivo 18F-flortaucipir PET does not accurately support the staging of progressive supranuclear palsy

Journal of Nuclear Medicine

Maura Malpetti

Sanne S Kaalund

Kamen A Tsvetanov

Timothy Rittman

Mayen Briggs

...

2022/7/1

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised …

EBioMedicine

Johannes Levin

Nand Sing

Sue Melbourne

Amber Morgan

Carla Mariner

...

2022/6/1

Age-dependent formation of TMEM106B amyloid filaments in human brains

Nature

Manuel Schweighauser

Diana Arseni

Mehtap Bacioglu

Melissa Huang

Sofia Lövestam

...

2022/5/12

Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons

Neuroscience

Maria Argyrofthalmidou

Alexia Polissidis

Sevasti Karaliota

Ioanna Papapanagiotou

Evangelos Sotiriou

...

2022/12/1

Exploring links between psychosis and frontotemporal dementia using multimodal machine learning: dementia praecox revisited

JAMA psychiatry

Nikolaos Koutsouleris

Christos Pantelis

Dennis Velakoulis

Philip McGuire

Dominic B Dwyer

...

2022/9/1

A tribute to John Q. Trojanowski (1946–2022), neuropathologist extraordinaire

Brain Pathology

Michel Goedert

Maria Grazia Spillantini

2022/5

See List of Professors in Maria Grazia Spillantini University(University of Cambridge)